FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.8400
-0.0300 (-3.45%)
May 13, 2025, 4:00 PM - Market closed
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $32.14 million as of May 14, 2025. Its market cap has decreased by -90.22% in one year.
Market Cap
32.14M
Enterprise Value
28.71M
1-Year Change
-90.22%
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $32.14M, a decrease of -96.60%. That is a compound annual growth rate of -92.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 32.14M | -54.20% |
| Dec 31, 2024 | 70.17M | -92.58% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |